Teacher Retirement System of Texas Trims Stock Position in Kenvue Inc. $KVUE

Teacher Retirement System of Texas decreased its position in shares of Kenvue Inc. (NYSE:KVUE) by 67.2% during the 3rd quarter, according to the company in its most recent disclosure with the SEC. The fund owned 296,256 shares of the company’s stock after selling 607,163 shares during the quarter. Teacher Retirement System of Texas’ holdings in Kenvue were worth $4,808,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors have also made changes to their positions in the company. Salomon & Ludwin LLC acquired a new position in Kenvue during the third quarter worth approximately $25,000. NBT Bank N A NY grew its position in shares of Kenvue by 180.3% during the third quarter. NBT Bank N A NY now owns 1,564 shares of the company’s stock worth $25,000 after acquiring an additional 1,006 shares during the last quarter. Trust Co. of Vermont increased its holdings in shares of Kenvue by 266.8% in the 2nd quarter. Trust Co. of Vermont now owns 1,581 shares of the company’s stock valued at $33,000 after acquiring an additional 1,150 shares during the period. New England Capital Financial Advisors LLC raised its position in Kenvue by 81.4% in the 3rd quarter. New England Capital Financial Advisors LLC now owns 2,563 shares of the company’s stock valued at $42,000 after purchasing an additional 1,150 shares during the last quarter. Finally, Future Financial Wealth Managment LLC acquired a new stake in Kenvue during the 3rd quarter worth $49,000. Institutional investors and hedge funds own 97.64% of the company’s stock.

Insider Buying and Selling at Kenvue

In other news, Director Jeffrey C. Smith acquired 3,200,000 shares of the company’s stock in a transaction that occurred on Friday, December 12th. The stock was purchased at an average cost of $17.37 per share, with a total value of $55,584,000.00. Following the purchase, the director directly owned 27,307,632 shares of the company’s stock, valued at approximately $474,333,567.84. This trade represents a 13.27% increase in their position. The acquisition was disclosed in a document filed with the SEC, which is available through the SEC website. 0.17% of the stock is currently owned by corporate insiders.

Analyst Upgrades and Downgrades

A number of research analysts have commented on the stock. Canaccord Genuity Group restated a “hold” rating and issued a $15.00 price objective (down from $26.00) on shares of Kenvue in a research note on Wednesday, October 29th. Deutsche Bank Aktiengesellschaft set a $18.00 price objective on Kenvue in a research report on Friday, October 24th. Citigroup dropped their target price on Kenvue from $20.00 to $17.00 and set a “neutral” rating on the stock in a report on Thursday, October 9th. Barclays increased their price target on Kenvue from $17.00 to $18.00 and gave the stock an “equal weight” rating in a report on Monday, November 10th. Finally, UBS Group lowered their price objective on shares of Kenvue from $23.00 to $17.00 and set a “neutral” rating on the stock in a research report on Wednesday, October 8th. One equities research analyst has rated the stock with a Strong Buy rating, five have issued a Buy rating and twelve have issued a Hold rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Hold” and an average price target of $20.23.

Kenvue Price Performance

Kenvue stock opened at $17.50 on Wednesday. The company has a market cap of $33.52 billion, a P/E ratio of 23.33 and a beta of 0.60. Kenvue Inc. has a one year low of $14.02 and a one year high of $25.17. The business has a fifty day moving average of $17.10 and a two-hundred day moving average of $18.08. The company has a debt-to-equity ratio of 0.66, a quick ratio of 0.69 and a current ratio of 0.98.

Kenvue (NYSE:KVUE) last announced its quarterly earnings results on Monday, November 3rd. The company reported $0.28 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.27 by $0.01. The business had revenue of $3.76 billion during the quarter, compared to the consensus estimate of $3.83 billion. Kenvue had a net margin of 9.55% and a return on equity of 20.02%. The business’s revenue was down 3.5% compared to the same quarter last year. During the same quarter last year, the firm posted $0.28 EPS. Kenvue has set its FY 2025 guidance at 1.000-1.050 EPS. As a group, analysts predict that Kenvue Inc. will post 1.14 earnings per share for the current fiscal year.

Kenvue Profile

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.